바이오제조 및 합성생물학 시장 예측(-2034년) : 기술 플랫폼, 제품 유형, 생물 시스템, 용도, 최종사용자, 지역별 세계 분석

According to Stratistics MRC, the Global Biomanufacturing & Synthetic Biology Market is accounted for $15.5 billion in 2026 and is expected to reach $45.2 billion by 2034 growing at a CAGR of 14.3% during the forecast period. Biomanufacturing and synthetic biology involve the application of engineering principles to biological systems to design, construct, and optimize living organisms for the production of valuable materials, chemicals, and therapeutics. They function by reprogramming cellular machinery, such as bacteria, yeast, or mammalian cells, to synthesize target compounds with high precision and efficiency. These technologies encompass precision fermentation, metabolic engineering, and AI-driven biological design. Their application ensures sustainable production of biofuels, alternative proteins, and pharmaceuticals, reducing reliance on traditional petrochemical processes globally.

Market Dynamics:

Driver:

Rising Demand for Sustainable and Bio-Based Alternatives

The escalating demand for sustainable and bio-based alternatives compels manufacturers to adopt biomanufacturing and synthetic biology solutions offering advanced production alternatives. Growing recognition of petrochemical environmental impacts is accelerating the integration of these biological systems into manufacturing frameworks. This transition is supported by advancements in metabolic engineering, which enhance cellular yield and efficiency. Consequently, enterprises are investing in synthetic biology technologies to achieve compliance with sustainability benchmarks while optimizing overall production costs.

Restraint:

Complex Regulatory Pathways and Scale-Up Challenges

The substantial expenses associated with scaling up advanced biomanufacturing and synthetic biology processes represent a significant barrier to widespread commercial adoption. Transitioning from laboratory-scale fermentation to industrial-scale bioreactors often requires complex process engineering and specialized technical expertise, which escalate overall implementation costs. Furthermore, the variability in biological systems limits the operational predictability of standardized production models. These factors collectively constrain market expansion, particularly for smaller enterprises with limited technology budgets.

Opportunity:

Expansion in Alternative Proteins and Biofuels

The alternative proteins and biofuels sectors present substantial growth opportunities for biomanufacturing and synthetic biology providers due to increasing demand for sustainable consumer goods. Advanced biological platforms offer a highly effective pathway to produce high-value compounds without extensive land use, utilizing precision fermentation as primary inputs. As global investments in green technology expand, the adoption of advanced synthetic biology solutions is expected to surge significantly.

Threat:

Competition from Traditional Petrochemical Manufacturing

The continuous reliance on traditional petrochemical manufacturing processes poses a considerable threat to the biomanufacturing and synthetic biology market. Conventional chemical synthesis often exhibits superior scalability and can be more cost-effective for facilities producing high-volume, commodity-grade materials. Additionally, the rapid advancement of basic chemical processing tools is enhancing the efficiency of conventional manufacturing methods. This competitive pressure may hinder market penetration in less specialized applications.

Covid-19 Impact:

The pandemic initially disrupted biomanufacturing deployments and delayed clinical trials due to supply chain constraints. However, the subsequent need for rapid vaccine and therapeutic production accelerated the adoption of synthetic biology solutions for resilient operations. Post-pandemic, the heightened focus on supply chain agility and operational efficiency has reinforced long-term investments in biomanufacturing technologies, driving robust market recovery and expansion across diverse industrial sectors globally.

The precision fermentation segment is expected to be the largest during the forecast period

The precision fermentation segment is expected to account for the largest market share during the forecast period, due to its unparalleled production efficiency and widespread applicability across diverse biomanufacturing environments. Precision fermentation offers exceptional cellular yield and operates effectively in complex biological conditions, which significantly reduces production time and minimizes resource consumption in daily manufacturing processes. As industries increasingly prioritize scalable and cost-effective bio-based production methods, the demand for specialized precision fermentation technologies continues to surge, thereby solidifying their dominant market position.

The AI-driven biological design segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the AI-driven biological design segment is predicted to witness the highest growth rate, driven by rapid advancements in machine learning and genomic sequencing techniques. These technologies enable the precise optimization of cellular pathways to produce highly specialized and robust biological outputs tailored for specific industrial applications. The ability to enhance production yield, operational scalability, and metabolic efficiency through advanced AI integration significantly improves process economics, accelerating commercial adoption globally.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to the presence of well-established biotechnology sectors and advanced research infrastructure that heavily utilize biomanufacturing and synthetic biology. The region benefits from substantial research and development investments, robust intellectual property protection, and supportive government initiatives promoting sustainable manufacturing and technological innovation. Furthermore, the early adoption of advanced synthetic biology technologies by key industry players in the United States and Canada reinforces the region's dominant position globally.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to rapid industrialization and expanding biotechnology sectors in emerging economies. Countries such as China, India, and Japan are increasingly investing in biomanufacturing infrastructure and advanced automation technologies to meet growing domestic production demands and stringent sustainability regulations. Additionally, favorable government policies, rising foreign direct investment, and the availability of cost-effective technological resources are collectively driving the accelerated adoption of synthetic biology across the region.

Key players in the market

Some of the key players in Biomanufacturing & Synthetic Biology Market include Novonesis A/S, DSM-Firmenich AG, Lonza Group AG, Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Sartorius AG, Evonik Industries AG, BASF SE, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Ginkgo Bioworks Holdings, Inc., Twist Bioscience Corporation, Codexis, Inc., Illumina, Inc., LanzaTech Global, Inc., GenScript Biotech Corporation, and Recursion Pharmaceuticals, Inc.

Key Developments:

In September 2026, Novonesis A/S launched a next-generation precision fermentation platform optimized for bio-based chemical production, achieving a thirty percent improvement in cellular yield while significantly reducing resource consumption requirements for global biomanufacturing operators.

In August 2026, DSM-Firmenich AG expanded its synthetic biology capacity through a strategic partnership with a leading genomics firm, enabling the scalable deployment of novel metabolic engineering modules for sustainable ingredient production.

In July 2026, Ginkgo Bioworks Holdings, Inc. secured a major supply agreement to provide customized biological design services for a prominent pharmaceutical company, facilitating the efficient integration of advanced synthetic biology tools into next-generation therapeutic ecosystems globally.

Technology Platforms Covered:

• Precision Fermentation
• Cell-Based Biomanufacturing
• Cell-Free Biomanufacturing
• Metabolic Engineering
• Protein Engineering
• Genome Engineering
• AI-Driven Biological Design
• Enzyme Engineering

Product Types Covered:

• Biopharmaceuticals
• Industrial Enzymes
• Biofuels
• Biochemicals
• Bioplastics and Biomaterials
• Alternative Proteins
• Agricultural Biologicals

Biological Systems Covered:

• Bacteria
• Yeast
• Fungi
• Mammalian Cells
• Plant Cells
• Cell-Free Systems
• Engineered Microbial Consortia

Applications Covered:

• Pharmaceutical Manufacturing
• Industrial Enzyme Production
• Food and Alternative Protein Production
• Biofuel Production
• Biochemical Manufacturing
• Bioplastics Manufacturing
• Agricultural Biotechnology
• Environmental Biotechnology

End Users Covered:

• Pharmaceutical and Biotechnology Companies
• Contract Development and Manufacturing Organizations (CDMOs)
• Food and Beverage Companies
• Chemical Companies
• Industrial Biotechnology Companies
• Agricultural Biotechnology Companies
• Research Institutions
• Consumer Products Companies

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Biomanufacturing & Synthetic Biology Market, By Technology Platform

• 5.1 Precision Fermentation
  • 5.1.1 Microbial Fermentation
  • 5.1.2 Yeast-Based Fermentation
  • 5.1.3 Bacterial Fermentation
  • 5.1.4 Fungal Fermentation
• 5.2 Cell-Based Biomanufacturing
  • 5.2.1 Mammalian Cell Culture
  • 5.2.2 Microbial Cell Culture
  • 5.2.3 Plant Cell Culture
• 5.3 Cell-Free Biomanufacturing
• 5.4 Metabolic Engineering
• 5.5 Protein Engineering
• 5.6 Genome Engineering
• 5.7 AI-Driven Biological Design
• 5.8 Enzyme Engineering

6 Global Biomanufacturing & Synthetic Biology Market, By Product Type

• 6.1 Biopharmaceuticals
  • 6.1.1 Monoclonal Antibodies
  • 6.1.2 Recombinant Proteins
  • 6.1.3 Vaccines
  • 6.1.4 Cell and Gene Therapies
• 6.2 Industrial Enzymes
• 6.3 Biofuels
  • 6.3.1 Bioethanol
  • 6.3.2 Biodiesel
  • 6.3.3 Sustainable Aviation Fuel
• 6.4 Biochemicals
• 6.5 Bioplastics and Biomaterials
• 6.6 Alternative Proteins
• 6.7 Agricultural Biologicals

7 Global Biomanufacturing & Synthetic Biology Market, By Biological System

• 7.1 Bacteria
• 7.2 Yeast
• 7.3 Fungi
• 7.4 Mammalian Cells
• 7.5 Plant Cells
• 7.6 Cell-Free Systems
• 7.7 Engineered Microbial Consortia

8 Global Biomanufacturing & Synthetic Biology Market, By Application

• 8.1 Pharmaceutical Manufacturing
• 8.2 Industrial Enzyme Production
• 8.3 Food and Alternative Protein Production
• 8.4 Biofuel Production
• 8.5 Biochemical Manufacturing
• 8.6 Bioplastics Manufacturing
• 8.7 Agricultural Biotechnology
• 8.8 Environmental Biotechnology

9 Global Biomanufacturing & Synthetic Biology Market, By End User

• 9.1 Pharmaceutical and Biotechnology Companies
• 9.2 Contract Development and Manufacturing Organizations
• 9.3 Food and Beverage Companies
• 9.4 Chemical Companies
• 9.5 Industrial Biotechnology Companies
• 9.6 Agricultural Biotechnology Companies
• 9.7 Research Institutions
• 9.8 Consumer Products Companies

10 Global Biomanufacturing & Synthetic Biology Market, By Geography

• 10.1 North America
  • 10.1.1 United States
  • 10.1.2 Canada
  • 10.1.3 Mexico
• 10.2 Europe
  • 10.2.1 United Kingdom
  • 10.2.2 Germany
  • 10.2.3 France
  • 10.2.4 Italy
  • 10.2.5 Spain
  • 10.2.6 Netherlands
  • 10.2.7 Belgium
  • 10.2.8 Sweden
  • 10.2.9 Switzerland
  • 10.2.10 Poland
  • 10.2.11 Rest of Europe
• 10.3 Asia Pacific
  • 10.3.1 China
  • 10.3.2 Japan
  • 10.3.3 India
  • 10.3.4 South Korea
  • 10.3.5 Australia
  • 10.3.6 Indonesia
  • 10.3.7 Thailand
  • 10.3.8 Malaysia
  • 10.3.9 Singapore
  • 10.3.10 Vietnam
  • 10.3.11 Rest of Asia Pacific
• 10.4 South America
  • 10.4.1 Brazil
  • 10.4.2 Argentina
  • 10.4.3 Colombia
  • 10.4.4 Chile
  • 10.4.5 Peru
  • 10.4.6 Rest of South America
• 10.5 Rest of the World (RoW)
  • 10.5.1 Middle East
    • 10.5.1.1 Saudi Arabia
    • 10.5.1.2 United Arab Emirates
    • 10.5.1.3 Qatar
    • 10.5.1.4 Israel
    • 10.5.1.5 Rest of Middle East
  • 10.5.2 Africa
    • 10.5.2.1 South Africa
    • 10.5.2.2 Egypt
    • 10.5.2.3 Morocco
    • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

• 11.1 Industry Value Network and Supply Chain Assessment
• 11.2 White-Space and Opportunity Mapping
• 11.3 Product Evolution and Market Life Cycle Analysis
• 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

• 12.1 Mergers and Acquisitions
• 12.2 Partnerships, Alliances, and Joint Ventures
• 12.3 New Product Launches and Certifications
• 12.4 Capacity Expansion and Investments
• 12.5 Other Strategic Initiatives

13 Company Profiling

• 13.1 Novonesis A/S
• 13.2 DSM-Firmenich AG
• 13.3 Lonza Group AG
• 13.4 Thermo Fisher Scientific Inc.
• 13.5 Danaher Corporation
• 13.6 Merck KGaA
• 13.7 Sartorius AG
• 13.8 Evonik Industries AG
• 13.9 BASF SE
• 13.10 Agilent Technologies, Inc.
• 13.11 Bio-Rad Laboratories, Inc.
• 13.12 Ginkgo Bioworks Holdings, Inc.
• 13.13 Twist Bioscience Corporation
• 13.14 Codexis, Inc.
• 13.15 Illumina, Inc.
• 13.16 LanzaTech Global, Inc.
• 13.17 GenScript Biotech Corporation
• 13.18 Recursion Pharmaceuticals, Inc.